Your session is about to expire
← Back to Search
Xltran for Post-COVID Syndrome
Study Summary
This trial is testing if two cannabis formulations can help treat Long COVID patients with prolonged symptoms. The trial is double-blind, meaning neither the patients nor the researchers know who is receiving the real treatment or the placebo.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have experienced improved energy levels and physical abilities due to any treatment within the last month.You have tried to harm yourself or have engaged in other dangerous behaviors in the past two years.You are allergic to hemp seeds, medical cannabis, sunflower lecithin, or polysorbate.You are currently using marijuana or medical cannabis.You have a mental health condition that is not well controlled, such as severe depression, anxiety, or obsessive-compulsive disorder. You also have a history of alcohol or drug abuse, or a serious mental illness like bipolar disorder or schizophrenia.Your body mass index (BMI) is either too low (below 20) or too high (above 40).
- Group 1: Xltran
- Group 2: Placebo
- Group 3: Xltranplus
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the overarching aims of this research endeavor?
"This clinical trial measures its primary outcome, the Change in PGIC from beginning to end of treatment at 30 days, using a Total Symptom Score (TSS). Secondary objectives include evaluation with the Insomnia Severity Index, Harvard Flourishing Index (HFI), and Hours of Upright Activity."
Is it permissible for participants under the age of twenty to join this clinical investigation?
"This trial is open to patients who are younger than 65 years of age and have reached the legal age of consent."
Is there an opportunity for me to be involved in this research initiative?
"Candidates must have the specified condition and be between 18-65 years old to qualify for this medical trial. Recruitment is estimated to take around 111 individuals."
Are there any current opportunities to join this clinical experiment?
"According to the data presented on clinicaltrials.gov, this trial is not presently enrolling patients; its first posting was made on October 1st 2022 and it has since been updated once, on August 1st 2022. Nonetheless, there are 1392 other medical studies actively recruiting volunteers at present."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger